CIK 0001295947 · Large accelerated filer
Prestige Consumer Healthcare Inc.
Sign in to watch- Ticker
- PBH
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Mar 31
- Entity type
- operating
- EIN
- 201297589
- Phone
- (914) 524-6800
- Business address
- 660 WHITE PLAINS RD., TARRYTOWN, NY, 10591
- Former names
- Prestige Brands Holdings, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-11-19 | Lombardi Ronald M. Chief Executive Officer | Option exercise · Employee Stock Options (right to buy) | −5,213 | 0 | ||
| 2024-11-19 | Lombardi Ronald M. Chief Executive Officer | Option exercise · Employee Stock Options (right to buy) | −5,662 | 0 | ||
| 2024-11-18 | Lombardi Ronald M. Chief Executive Officer | Option exercise | +48,512 | $57.18 | $2.8M | 369,464 |
| 2024-11-18 | Lombardi Ronald M. Chief Executive Officer | Sale | −48,512 | $82.67 | $4.0M | 320,952 |
| 2024-11-18 | Lombardi Ronald M. Chief Executive Officer | Option exercise | +33,725 | $56.11 | $1.9M | 354,677 |
| 2024-11-18 | Lombardi Ronald M. Chief Executive Officer | Sale | −33,725 | $82.41 | $2.8M | 320,952 |
| 2024-11-18 | Lombardi Ronald M. Chief Executive Officer | Option exercise · Employee Stock Options (right to buy) | −48,512 | 5,213 | ||
| 2024-11-18 | Lombardi Ronald M. Chief Executive Officer | Option exercise · Employee Stock Options (right to buy) | −33,725 | 5,662 | ||
| 2024-11-12 | P'Pool William See Remarks | Sale | −8,987 | $81.85 | $736K | 20,058 |
| 2024-11-12 | Sacco Christine Chief Financial Officer | Option exercise | +24,686 | $30.56 | $754K | 54,809 |
| 2024-11-12 | Sacco Christine Chief Financial Officer | Sale | −24,686 | $82.01 | $2.0M | 30,123 |
| 2024-11-12 | Sacco Christine Chief Financial Officer | Option exercise · Employee Stock Options (rights to buy) | −24,686 | 0 | ||
| 2024-11-12 | Mekhail Adel EVP, Marketing & Sales | Option exercise | +5,565 | $44.33 | $247K | 27,428 |
| 2024-11-12 | Mekhail Adel EVP, Marketing & Sales | Sale | −9,063 | $82.00 | $743K | 18,365 |
| 2024-11-12 | Mekhail Adel EVP, Marketing & Sales | Option exercise · Employee Stock Options (rights to buy) | −5,565 | 5,400 | ||
| 2024-11-12 | Fritz Mary Beth SVP Quality & Regulatory | Grant or award | +6,471 | $39.98 | $259K | 25,306 |
| 2024-11-12 | Fritz Mary Beth SVP Quality & Regulatory | Sale | −6,471 | $81.99 | $531K | 18,835 |
| 2024-11-12 | Fritz Mary Beth SVP Quality & Regulatory | Grant or award | +3,414 | $54.47 | $186K | 22,249 |
| 2024-11-12 | Fritz Mary Beth SVP Quality & Regulatory | Sale | −3,414 | $81.93 | $280K | 18,835 |
| 2024-11-12 | Fritz Mary Beth SVP Quality & Regulatory | Option exercise · Employee Stock Options (right to buy) | −6,471 | 0 |
Page 6 of 12 · 225 trades